Legend Stock Today

LEGN
 Stock
  

USD 40.19  0.72  1.76%   

Market Performance
0 of 100
Odds Of Distress
Less than 26
Legend Biotech is selling for 40.19 as of the 7th of October 2022. This is a -1.76 percent decrease since the beginning of the trading day. The stock's open price was 40.91. Legend Biotech has about a 26 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Legend Biotech Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 17th of October 2020 and ending today, the 7th of October 2022. Click here to learn more.
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation. The company has 152.83 M outstanding shares of which 4.27 M shares are now shorted by private and institutional investors with about 6.69 trading days to cover. More on Legend Biotech Corp

Moving together with Legend Biotech

+0.8MRNAModerna Potential GrowthPairCorr
+0.81INTCIntel Corp TrendingPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Legend Biotech Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Legend Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Legend Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Legend Biotech Corp generated a negative expected return over the last 90 days
Legend Biotech Corp has high historical volatility and very poor performance
The company reported the previous year's revenue of 119 M. Net Loss for the year was (346.4 M) with profit before overhead, payroll, taxes, and interest of 91.56 M.
Legend Biotech Corp currently holds about 791.26 M in cash with (250.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11.
Latest headline from Macroaxis: Is Legend riskier than Paylocity Holdings Corp
Average Analyst Recommendation
Analysts covering Legend Biotech report their recommendations after researching Legend Biotech's financial statements, talking to executives and customers, or listening in on Legend Biotech's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Legend Biotech Corp. The Legend consensus assessment is calculated by taking the average forecast from all of the analysts covering Legend Biotech.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Legend Biotech's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellUndervalued
Legend Biotech Corp (LEGN) is traded on NASDAQ Exchange in USA and employs 1,071 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 6.16 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Legend Biotech's market, we take the total number of its shares issued and multiply it by Legend Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Legend Biotech Corp conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 152.83 M outstanding shares of which 4.27 M shares are now shorted by private and institutional investors with about 6.69 trading days to cover. Legend Biotech Corp currently holds about 791.26 M in cash with (250.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11.
Check Legend Biotech Probability Of Bankruptcy
Ownership
Legend Biotech Corp maintains a total of one hundred fifty-two million eight hundred thirty thousand outstanding shares. 30% of Legend Biotech outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Please note that no matter how much assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Legend Ownership Details

Legend Stock Price Odds Analysis

Proceeding from a normal probability distribution, the odds of Legend Biotech jumping above the current price in 90 days from now is about 90.53%. The Legend Biotech Corp probability density function shows the probability of Legend Biotech stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Legend Biotech has a beta of 0.8636. This indicates Legend Biotech Corp market returns are very sensitive to returns on the market. As the market goes up or down, Legend Biotech is expected to follow. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Legend Biotech Corp is significantly underperforming DOW.
  Odds Below 40.19HorizonTargetOdds Above 40.19
9.41%90 days
 40.19 
90.53%
Based on a normal probability distribution, the odds of Legend Biotech to move above the current price in 90 days from now is about 90.53 (This Legend Biotech Corp probability density function shows the probability of Legend Stock to fall within a particular range of prices over 90 days) .

Legend Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Legend Biotech that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Legend Biotech's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Legend Biotech's value.
InstituionSecurity TypeTotal SharesValue
Fmr LlcCommon Shares6.7 M366.5 M
Hhlr Advisors LtdCommon Shares4.4 M244 M
View Legend Biotech Diagnostics

Legend Biotech Corp Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Legend Biotech market risk premium is the additional return an investor will receive from holding Legend Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Legend Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Legend Biotech's alpha and beta are two of the key measurements used to evaluate Legend Biotech's performance over the market, the standard measures of volatility play an important role as well.

Legend Stock Against Markets

Picking the right benchmark for Legend Biotech stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Legend Biotech stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Legend Biotech is critical whether you are bullish or bearish towards Legend Biotech Corp at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Legend Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

Invested in Legend Biotech Corp?

The danger of trading Legend Biotech Corp is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Legend Biotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Legend Biotech. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Legend Biotech Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, see Correlation Analysis. Note that the Legend Biotech Corp information on this page should be used as a complementary analysis to other Legend Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Legend Stock analysis

When running Legend Biotech Corp price analysis, check to measure Legend Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend Biotech is operating at the current time. Most of Legend Biotech's value examination focuses on studying past and present price action to predict the probability of Legend Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Legend Biotech's price. Additionally, you may evaluate how the addition of Legend Biotech to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Is Legend Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Legend Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.